Amyl Therapeutics is a preclinical stage biotechnology company.
Business Model:
Revenue: $0
Employees: 0-0
Address: 98 ALLEE DE LA ROUGE CENSE
City: LIÈGE
State: walloon brabant
Zip: 4301
Country: BE
Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β (Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer&s;s and Parkinson&s;s diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2021 | Grant | 1 | $11.8M |
Directorate General operational for Economy, Employment and Research Directorate General operational for Economy, Employment and Research |
6/2021 | Series A | $0 |
6K Venture Capital Ifoghas Investments Kenneth Buckfire Merieux Developpement Meusinvest (Noshaq) Sambrinvest Smedvig 6K Venture Capital Ifoghas Investments Kenneth Buckfire Merieux Developpement Meusinvest (Noshaq) Sambrinvest Smedvig |
6/2021 | Series A | $22.3M |
Noshaq Sambrinvest Merieux Equity Partners |
6/2021 | Series A | 7 | $10.4M |
6K Venture Capital Ifoghas Investments Kenneth Buckfire Merieux Developpement Meusinvest (Noshaq) Sambrinvest Smedvig 6K Venture Capital Ifoghas Investments Kenneth Buckfire Merieux Developpement Meusinvest (Noshaq) Sambrinvest Smedvig |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|